These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21186201

  • 1. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D.
    Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
    [Abstract] [Full Text] [Related]

  • 2. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS.
    J Immunol; 2003 Dec 15; 171(12):6910-8. PubMed ID: 14662898
    [Abstract] [Full Text] [Related]

  • 3. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.
    J Immunol; 1999 Aug 01; 163(3):1647-53. PubMed ID: 10415070
    [Abstract] [Full Text] [Related]

  • 4. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A.
    Am J Ind Med; 2004 Aug 01; 46(2):95-103. PubMed ID: 15273960
    [Abstract] [Full Text] [Related]

  • 5. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
    Amicosante M, Berretta F, Rossman M, Butler RH, Rogliani P, van den Berg-Loonen E, Saltini C.
    Respir Res; 2005 Aug 14; 6(1):94. PubMed ID: 16098233
    [Abstract] [Full Text] [Related]

  • 6. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
    Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA.
    Tissue Antigens; 2007 Dec 14; 70(6):480-6. PubMed ID: 17927685
    [Abstract] [Full Text] [Related]

  • 7. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
    Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12717-22. PubMed ID: 11050177
    [Abstract] [Full Text] [Related]

  • 8. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
    Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP.
    J Immunol; 2005 Nov 15; 175(10):7029-37. PubMed ID: 16272364
    [Abstract] [Full Text] [Related]

  • 9. Genetic determinants of sensitivity to beryllium in mice.
    Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.
    J Immunotoxicol; 2009 Jun 15; 6(2):130-5. PubMed ID: 19589099
    [Abstract] [Full Text] [Related]

  • 10. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI, Amicosante M, Schürmann M, Fireman E, Saltini C, Müller-Quernheim J.
    J Mol Med (Berl); 2005 May 15; 83(5):397-405. PubMed ID: 15750822
    [Abstract] [Full Text] [Related]

  • 11. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
    Richeldi L, Sorrentino R, Saltini C.
    Science; 1993 Oct 08; 262(5131):242-4. PubMed ID: 8105536
    [Abstract] [Full Text] [Related]

  • 12. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization.
    Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, Lagan AL, Lympany P, Sawyer RT, du Bois RM, Welsh KI, Maier LA.
    J Allergy Clin Immunol; 2007 Mar 08; 119(3):687-96. PubMed ID: 17208287
    [Abstract] [Full Text] [Related]

  • 13. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C.
    Eur Respir J; 2001 Oct 08; 18(4):677-84. PubMed ID: 11716174
    [Abstract] [Full Text] [Related]

  • 14. HLA-DPB1 and chronic beryllium disease: a HuGE review.
    McCanlies EC, Kreiss K, Andrew M, Weston A.
    Am J Epidemiol; 2003 Mar 01; 157(5):388-98. PubMed ID: 12615603
    [Abstract] [Full Text] [Related]

  • 15. Polymorphism of HLA-DRB1, -DQB1 and -DPB1 genes in Bai ethnic group in southwestern China.
    Hu W, Tang L, Wang J, Wang B, Li S, Yu H, Tang W, Li H, Tan S, Shou W, Xiao C.
    Tissue Antigens; 2008 Nov 01; 72(5):474-7. PubMed ID: 18778327
    [Abstract] [Full Text] [Related]

  • 16. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP, Maier LA.
    Trends Immunol; 2005 Oct 01; 26(10):543-9. PubMed ID: 16099719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunology of chronic beryllium disease.
    Samuel G, Maier LA.
    Curr Opin Allergy Clin Immunol; 2008 Apr 01; 8(2):126-34. PubMed ID: 18317020
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
    McCleskey TM, Buchner V, Field RW, Scott BL.
    Rev Environ Health; 2009 Apr 01; 24(2):75-115. PubMed ID: 19658317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.